Mechanistic Deconstruction: Exploring the Core Principles of LLPS
The concept of liquid-liquid phase separation (LLPS) can be traced back to early theoretical hypotheses regarding the behavior
of cytoplasmic droplets. Between 2009 and 2012, key technological advances—particularly in vitro reconstruction
and visualization of dynamic phase transitions in protein/RNA systems—enabled LLPS research to shift from purely phenomenological
observations to more mechanistic studies[1].
At the molecular level, LLPS is primarily driven by weak intermolecular interactions between multivalent molecules, including electrostatic
forces, π-π stacking, cation-π interactions, and hydrophobic effects. Functionally, LLPS contributes to physiological processes such
as immune response, gene transcription regulation, and signal transduction by locally enriching specific molecular components,
which can enhance reaction efficiency and specificity. Dysregulated phase separation can cause normally dynamic condensates to
transition into aberrantly stable assemblies or aggregates, potentially disrupting cellular homeostasis[2][3]. Such abnormal
behaviors are implicated in the onset and progression of diseases including cancer and neurodegenerative disorders, highlighting the
importance of studying LLPS mechanisms.
Key Forces Driving LLPS
The formation of LLPS relies on weak intermolecular interactions that govern the local enrichment and dynamic rearrangement of molecules within cells. These key forces can be categorized into two types:
1. Intermolecular Interactions
• Protein-protein, protein-RNA, and RNA-RNA interactions: Multivalent binding sites or repetitive structural domains facilitate molecular crosslinking, promoting the formation of concentrated droplets.
• Weak, transient interactions by intrinsically disordered regions (IDRs): IDRs lack fixed three-dimensional structures but can engage
in dynamic binding through aromatic residues and charged residues. These interactions include π-π stacking (aromatic side-chain
interactions such as Phe, Tyr, Trp), cation-π interactions (positive residues such as Lys and Arg interacting with aromatics),
salt bridges, and dipole-dipole interactions of polar amino acids such as Gln and Asn.
2. Macroscopic Driving Forces
• LLPS is also influenced by local concentration differences within the cell. These microenvironment gradients, established by multivalent
weak interactions, help organize molecules within droplets and regulate the dynamics of molecule ingress and egress, contributing to the
reversibility and responsiveness of phase-separated assemblies.
• The combined effect of these forces allows droplets to maintain liquid-like properties (e.g., fusion, formation, and fission) while
remaining sensitive to temperature, ionic strength, and post-translational modifications, enabling cells to adapt quickly to environmental
changes and signaling events[2][3][4].
Overall, LLPS is driven by a combination of reversible, weak, multivalent interactions and macroscopic gradients, which together explain the dynamic behavior of intracellular condensates.
Figure 1. Comprehensive mechanism of LLPS[4].
Regulation of LLPS
LLPS is regulated by a multilayered network involving post-translational modifications, RNA, ATP, and environmental factors. Phosphorylation
and other modifications can modulate phase separation. RNA influences condensate dynamics through a biphasic concentration-dependent effect
and its structural features. ATP similarly plays dual roles, acting as a modulator of protein interactions and, under crowded conditions,
undergoing independent phase separation. Environmental changes such as pH, temperature, ionic strength, and molecular crowding also regulate
LLPS to ensure proper spatiotemporal formation and disassembly.
ATP Regulation
ATP regulation of LLPS is concentration-dependent. At low concentrations, ATP promotes phase separation of multivalent
proteins (e.g., FUS and TDP-43) through electrostatic and cation-π interactions. At higher concentrations, ATP can inhibit or
dissolve condensates, maintaining protein homeostasis. ATP also interacts with intrinsically disordered regions (IDRs) and can
phase separate independently in crowded environments. This bidirectional regulation provides the cell with a finely tuned
metabolic-phase separation coupling mechanism[5][6][7].
Figure 2. The impact of ATP on the LLPS of positively charged proteins[5].
RNA Biphasic Regulation
RNA exhibits concentration-dependent biphasic regulation—promoting phase separation at low concentrations and inhibiting it at high concentrations[8]. Additional regulatory layers include:
• RNA Length: Short RNAs accumulate on droplet surfaces as "surfactants", whereas long RNAs penetrate cores to stabilize networks[9].
• RNA Structure: Single- and double-stranded RNA can partition differently, affecting stability and sorting[10].
• RNA Modifications: N6-methyladenosine (m6A) modification recruits YTHDF proteins, influencing mRNA metabolism in condensates[11].
• Protein Collaboration: mRNA scaffold proteins such as FUS and TDP-43, preventing pathological aggregation[12].
Figure 3. RNA regulation of prion-like RBP phase behavior[8].
Physiological Functions of LLPS
LLPS drives the formation of membrane-less organelles, allowing precise regulation of cellular processes without lipid membranes. Key
functions include gene expression regulation, signal transduction, stress response, DNA damage repair, RNA metabolism, and cell
differentiation. Disruption of LLPS dynamics can contribute to a range of diseases, including neurodegenerative diseases, cancer,
developmental defects, and viral infections[13][14].
Figure 4. Functions of biomolecular condensates[15].
A. Role of LLPS in signal transduction. B. Role of LLPS in transcriptional regulation. C. Role of LLPS in autophagy. D. Role of LLPS in DNA damage repair
Technological Implementation: Cutting-edge Tools for LLPS Research
To systematically deconstruct the mechanisms and biological implications of Liquid-Liquid Phase Separation (LLPS), a diverse array of
methodologies has been employed, ranging from in silico sequence analysis and structural prediction to high-resolution biophysical
characterization and precision spatiotemporal manipulation. These approaches can be categorized into three hierarchical stages:
identification and mapping, biophysical characterization, and precision engineering.
Figure 5. Methods for identifying LLPS[4].
a. Bioinformatics tools or databases for LLPS research. b. Electron microscopy, confocal microscopy, and super-resolution imaging techniques for detailed information on biomolecular condensates. c. In vitro reconstitution of proteins to validate phase separation conditions. d. Fluorescence Recovery After Photobleaching (FRAP) to detect the properties and dynamic changes of biomolecular condensates. e. The OptoDroplet system uses blue light to modulate multivalency, thus promoting or reversing biomolecular condensate formation in vivo.
Identification & Mapping: From Bioinformatics to the "Droplet-ome"
The exploration of LLPS typically begins with the computational assessment of protein phase-separation propensity. Bioinformatics
platforms (e.g., D2P2, PhaSePro, and LLPSDB) analyze sequences for intrinsically disordered regions (IDRs) and multivalent
interaction motifs[16][17]. Current predictive frameworks are guided by the "stickers-and-spacers" model, in which specific
residues—particularly aromatic "stickers" (Phe, Tyr, Trp)—and low-complexity domains (LCDs) govern intermolecular
interactions, thereby dictating phase behavior and solubility boundaries[18].
The 2024 deployment of AlphaFold 3 represents a major advance in structure prediction, enabling modeling of heteromeric complexes that
may include intrinsically disordered regions, and providing structural hypotheses for molecular interfaces potentially involved in
phase separation[19].
Deciphering the molecular architecture of the "droplet-ome" requires high-throughput biochemical mapping. Because biomolecular condensates
lack delimiting membranes, they are highly sensitive to dilution-induced dissolution during conventional cell lysis. To preserve these
transient interactions, proximity labeling (PL), utilizing engineered enzymes such as TurboID or APEX2, has emerged as an effective
strategy for mapping condensate-associated proteomes[20][21]. By covalently tagging neighboring proteins and RNAs with biotin in their
native cellular environment, PL captures a molecular "snapshot" of the condensate. These labeled species can then be enriched using
streptavidin-based purification, enabling high-sensitivity identification via mass spectrometry or RNA sequencing.
Spatiotemporal Visualization & Biophysical Characterization
Microscopy remains the cornerstone for visualizing the hierarchical organization of biomolecular condensates. Advanced imaging modalities,
including super-resolution techniques (e.g., STED and STORM) and electron microscopy, have revealed that many condensates exhibit spatially
heterogeneous architectures, such as core–shell organization, as exemplified by SARS-CoV-2 nucleocapsid protein assemblies[22]. This
structural heterogeneity supports functional compartmentalization between dense cores and more dynamic peripheral regions.
To probe the viscoelastic properties and molecular dynamics within condensates, fluorescence recovery after photobleaching (FRAP) and
fluorescence correlation spectroscopy (FCS) are widely used. FRAP recovery kinetics, characterized by the mobile fraction and recovery
half-time (t1/2), provide insights into molecular mobility and can indicate transitions toward less dynamic,
gel-like or solid-like states[23].
Recent advances have integrated imaging with in vitro reconstitution systems, particularly giant unilamellar vesicle (GUV) assays, to
investigate condensate–membrane interactions. This approach enables the quantification of interfacial parameters such as surface
tension (σ), wetting contact angles, and line tension (λ)[24]. Complementing these experimental advances, theoretical frameworks
have elucidated how membrane-anchored "mobile tethers"—proteins or lipids that diffuse within the membrane while engaging with
condensates—modulate wetting properties by enriching at the condensate-membrane interface, thereby altering surface tension and contact
angles[25]. These tether-mediated interactions further govern condensate behavior in complex membrane geometries, including localization
to membrane junctions and migration along membrane tubules[25].
Precision Manipulation: From Dynamics to Phase Engineering
Establishing the functional roles of LLPS requires the ability to perturb condensate formation with high spatiotemporal precision. Optogenetic
systems, such as the Corelet platform utilizing photo-responsive domains (e.g., iLID/SspB with ferritin oligomerization), enable
light-dependent induction of multivalent interactions in living cells[26]. This approach facilitates controlled modulation of phase
behavior and estimation of critical saturation concentration (Csat) thresholds under physiological conditions.
Beyond fundamental studies, LLPS is increasingly being harnessed for phase engineering in synthetic biology. Recent studies demonstrate
that isothermal nucleic acid amplification processes, such as recombinase polymerase amplification (RPA), can be accelerated by the
formation of multiphase condensates that concentrate reactants and enhance reaction kinetics[27].
Building on this concept, nucleic acid nanotechnology has been integrated with CRISPR-Cas12a systems to achieve programmable control over
reaction dynamics and specificity[28]. These programmable systems, mediated by toehold-mediated strand displacement reactions that
modulate crRNA conformational states, function as synthetic microreactors, offering emerging opportunities for molecular diagnostics
and metabolic engineering.
LLPS Applications: From Basic Research to Engineering Applications
LLPS research has progressed from initial exploration of fundamental biological principles to the forefront of technological translation
and engineering applications. It is no longer just a framework for explaining cellular organization, but has become a "toolbox" offering
innovative solutions across multiple fields, including drug delivery, synthetic biology, biomaterials,
and disease diagnosis and treatment[4][29][30].
Notably, understanding and manipulating LLPS now enables precise control over molecular organization, opening avenues for therapeutic and engineering innovations.
Phase Separation in Neurodegenerative Diseases
One of the first significant translational directions for LLPS research is understanding its role in diseases and opening new therapeutic avenues. Emerging evidence indicates that abnormal LLPS drives pathological aggregation, providing novel molecular targets for intervention in cancer, neurodegenerative diseases, and viral infections. Studying the effects of mutations and post-translational modifications (PTMs) is crucial for disease mechanism elucidation and drug development.
For example, targeting proteins with phase separation tendencies, such as TDP-43 and Tau, can fundamentally suppress their abnormal
aggregation, highlighting potential therapeutic strategies in ALS and Alzheimer's disease[29].
Figure 6. Phase separation in neurodegenerative diseases[4].
LLPS in Cancer
Cancer is often closely related to gene mutations and transcriptional dysregulation, and LLPS provides new perspectives for understanding
these mechanisms[31]. At the gene mutation level, the tumor suppressor protein SPOP forms condensates through LLPS to promote the
degradation of oncogenes. Mutations in SPOP disrupt condensate formation, leading to substrate accumulation and promoting
tumorigenesis. Similarly, mutant SHP2 can abnormally activate downstream signaling pathways (such as the MAPK pathway) via LLPS,
driving tumor progression. Research on AKAP95 has shown that appropriate fluidity of condensates is critical for their regulatory
role in gene expression and carcinogenesis. Disruption of condensate dynamics may serve as a key driver of cancer development.
In transcriptional regulation, coactivators like YAP/TAZ form condensates through LLPS to activate gene expression. Under normal
physiological conditions, the Hippo signaling pathway inhibits their activity, but in cancer, this pathway is inactivated,
leading to the accumulation of YAP/TAZ and enhanced transcriptional activity of proto-oncogenes via LLPS. Targeting YAP/TAZ
condensates may offer strategies to overcome therapy resistance and block oncogenic transcription[4].
In summary, abnormal LLPS—such as blocked or overactive condensate formation— is closely linked to cancer, providing novel strategies
to target previously “undruggable” proteins. These strategies may also apply to other LLPS-dependent diseases, such as neurodegenerative disorders.
Figure 7. LLPS in cancer[4].
LLPS in SARS-CoV-2 Infection
LLPS plays a critical role in viral infections and host immune responses, providing a novel research framework for understanding
infection mechanisms. Condensate dynamics are essential for viral replication efficiency and genome packaging. In the case of
COVID-19, the nucleocapsid protein (N protein) of SARS-CoV-2 forms condensates with RNA through LLPS, participating in the
replication, processing, and packaging of the viral genome. This process is regulated by several factors: for example, Zn2+
can promote N protein phase separation, while different RNA sequences modulate condensate formation by either promoting or
inhibiting it[32].
The material state of N protein condensates is closely linked to function: when unphosphorylated, N protein forms gel-like structures
conducive to stable genome packaging; upon phosphorylation of the SR region, the N protein transitions to more liquid-like droplets,
regulating RNA processing and replication. Additionally, N protein can interact with the membrane protein (M protein) to form
condensates and, in the presence of RNA, form a "core-shell" double-layer structure facilitating
viral particle assembly[33].
Targeting these LLPS-driven processes may offer novel antiviral strategies by disrupting critical condensates during the viral lifecycle.
Figure 8. LLPS in SARS-CoV-2 infection[4].
Summary
Liquid-liquid phase separation (LLPS) provides a fundamental framework for understanding intracellular organization. It is driven by weak
multivalent interactions, concentration gradients, and modulatory factors such as RNA and ATP, enabling the dynamic formation of
membrane-less condensates that regulate key cellular processes, including gene expression, signal transduction, stress
responses, and protein homeostasis. Dysregulation of LLPS is implicated in diseases such as neurodegeneration, cancer, and viral infections.
Recent advances in computational prediction, high-resolution imaging, proximity labeling, and optogenetic manipulation allow researchers
to map, characterize, and perturb biomolecular condensates with unprecedented precision. These approaches facilitate a deeper
understanding of LLPS mechanisms and dynamics, providing a solid foundation for exploring potential therapeutic
interventions and engineering applications in the future.
Recommended Magnetic Beads for Protein Purification
| Product Name |
Cat. No. |
Description |
| Protein A/G Magnetic Beads |
HY-K0202 |
Immunoprecipitation (IP), Co-immunoprecipitation (Co-IP), Protein Purification |
| Streptavidin Magnetic Beads |
HY-K0208 |
Immunoprecipitation (IP), Co-immunoprecipitation (Co-IP), Protein Purification, ChIP, RIP |
| Anti-Flag Magnetic Beads |
HY-K0207 |
Immunoprecipitation (IP), Co-immunoprecipitation (Co-IP), Protein Purification |
| Oligo (dT)30 Magnetic Beads |
HY-K0228 |
RIP, RT-PCR, cDNA Library Construction |
| Anti-GFP Magnetic Agarose Beads |
HY-K0246 |
Immunoprecipitation (IP), Co-immunoprecipitation (Co-IP), Protein Purification |
References
[1]
Brangwynne CP, et al. Science. 2009 Jun 26;324(5935):1729-32.
[2]
Hyman AA, et al. Annu Rev Cell Dev Biol. 2014;30:39-58.
[3]
Banani SF, et al. Nat Rev Mol Cell Biol. 2017 May;18(5):285-298.
[4]
Wang B, et al. Signal Transduct Target Ther. 2021 Aug 2;6(1):290.
[5]
Hautke A, et al. Biol Chem. 2023 Sep 4;404(10):897-908.
[6]
Kang J, et al. Biochem Biophys Res Commun. 2018 Oct 2;504(2):545-551.
[7]
Liu F, et al. JACS Au. 2023 Sep 4;3(9):2578-2585.
[8]
Maharana S, et al. Science. 2018 May 25;360(6391):918-921.
[9]
Sanchez-Burgos I, et al. Biophys J. 2023 Jul 25;122(14):2973-2987.
[10]
Choi S, et al. Nat Chem. 2022 Oct;14(10):1110-1117.
[11]
Ries RJ, et al. Nature. 2019 Jul;571(7765):424-428.
[12]
Demongin C, et al. J Biol Chem. 2024 Mar;300(3):105716.
[13]
Li Q, et al. Front Cell Dev Biol. 2026 Jan 21;14:1759561.
[14]
Wang YL, et al. Cell Death Dis. 2023 Nov 15;14(11):746.
[15]
Qiu X, et al. iScience. 2025 Oct 24;28(11):113843.
[16]
Mészáros B, et al. Nucleic Acids Res. 2020 Jan 8;48(D1):D360-D367.
[17]
Li Q, et al. Nucleic Acids Res. 2020 Jan 8;48(D1):D320-D327.
[18]
Martin EW, et al. Science. 2020 Feb 7;367(6478):694-699.
[19]
Abramson J, et al. Nature. 2024 Jun;630(8016):493-500.
[20]
Youn JY, et al. Mol Cell. 2019 Oct 17;76(2):286-294.
[21]
Qin W, et al. Nat Methods. 2021 Feb;18(2):133-143.
[22]
Lu S, et al. Nat Commun. 2021 Jan 21;12(1):502.
[23]
Alberti S, et al. J Mol Biol. 2018 Nov 2;430(23):4806-4820.
[24]
Wang Y, et al. Nature. 2024 Oct;634(8036):1204-1210.
[25]
Yu Q, et al. bioRxiv [Preprint]. 2025 Oct 28:2024.12.04.626804.
[26]
Bracha D, et al. Cell. 2018 Nov 29;175(6):1467-1480.e13.
[27]
Homchan A, et al. J Am Chem Soc. 2025 Mar 26;147(12):10088-10103.
[28]
Zhao R, et al. Nucleic Acids Res. 2023 Oct 27;51(19):10795-10807.
[29]
Chen L, et al. J Control Release. 2026 Feb 10;390:114516.
[30]
Zheng LW, et al. J Hematol Oncol. 2023 Dec 18;16(1):123.
[31]
Jian Q, et al. Front Immunol. 2025 Jun 26;16:1604015.
[32]
Favetta B, et al. Nat Commun. 2025 Aug 26;16(1):7970.
[33]
Lu S, et al. Nat Commun. 2021 Jan 21;12(1):502.
LinkedIn
Researchgate
Facebook
X
Instagram
Mail
Mechanistic Deconstruction: Exploring the Core Principles of LLPS
Technical Implementation: Cutting-Edge Tools for LLPS Research
Application Prospects: From Basic Research to Engineering Applications
